CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.260

-3.8%

Nov 11 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (365)	3/2/2001 1:27:15 PM
From: Icebrg	Read Replies (1) of 668

Jim, Dr. Garren is sometimes a little bit careless with some of the details. I don't think OP-1 is approved in Australia yet. It has been recommended for approval, though. Exactly as in Europe. "CAMBRIDGE, Mass.--(BW HealthWire)--Feb. 16, 2001--Curis, Inc. (NASDAQ:CRIS - news) today commented on an announcement from Stryker Corporation (NYSE:SYK - news) regarding the positive opinion of the Australian Drug Evaluation Committee (ADEC) to recommend the granting of marketing authorization for OP-1 Implant (Osteogenic Protein 1) in Australia. OP-1, under license by Curis to Stryker Corporation for orthopaedic and periodontal indications in exchange for royalty payments as a percentage of sales, is the first biotechnology product recommended for use specifically in the field of orthopaedic medicine." biz.yahoo.com Ice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next